The New England Newborn Screening Program developed, validated, and implemented a screening algorithm for the detection of SMA-affected infants who show absent SMN1 Exon 7 by Real-TimeTM quantitative PCR (qPCR). Here, SMN1 is linked to proximal spinal muscular atrophy.